NCT00477217View on ClinicalTrials.gov

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Osteonecrosis

Interventions

DRUG

Zoledronic acid

Trial Locations (1)

NSW,2072

Novartis Investigative Site, Gordon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY